Zobrazeno 1 - 10
of 278
pro vyhledávání: '"Fang,Bian"'
Autor:
Xiaoling Cai, Linong Ji, Mingxia Yuan, Jianhua Ma, Fang Bian, Sheli Li, Wuyan Pang, Shuang Yan, Huimin Zhou, Minghui Hou, Wenhui Li, Ying Jia, Li Liu, Ke Ding, Michael Xu
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 51, Iss , Pp 101197- (2024)
Summary: Background: Visepegenatide, a once-weekly glucagon-like peptide-1 receptor agonist injection, demonstrated effective glycaemic control and good tolerability without the requirement of dose titration in the two completed phase 2 studies. We a
Externí odkaz:
https://doaj.org/article/41923e3bab6b46929eafd3806d8a14b0
Autor:
Kirk Patrick Carreon Catral, Choi-Yee Tse, Wei-Ying Yang, Choi-Ying Ling, Oi-Lam Kwok, Kit-Ying Choy, Da-Qian Lu, Jing-Fang Bian, Thomas Chuen Lam, Dennis Yan-Yin Tse, Samantha Sze-Wan Shan
Publikováno v:
Cells, Vol 13, Iss 22, p 1907 (2024)
Age-related macular degeneration (AMD) is a degenerative eye disease leading to central vision loss and is characterized by dysregulated autophagy of the retinal pigment epithelium (RPE) layer. Recent studies have suggested that rho-associated protei
Externí odkaz:
https://doaj.org/article/b8ef45dad96d4e2a9df365739447690e
Autor:
Lingding Xie, Jie Han, Zhifeng Cheng, Dexue Liu, Jie Liu, Chunrong Xu, Wenli Sun, Qingju Li, Fang Bian, Wei Zhang, Jinyu Chen, Qian Zhu, Tara K. Thurber, J. Paul Lock, Bo Zhang
Publikováno v:
Journal of Diabetes, Vol 16, Iss 4, Pp n/a-n/a (2024)
Abstract Background Bexagliflozin and dapagliflozin are sodium‐glucose cotransporter‐2 (SGLT2) inhibitors. No direct comparison of SGLT2 inhibitors in a randomized controlled trial has been reported to date. Methods This was a multicenter, random
Externí odkaz:
https://doaj.org/article/981ab9215aba4b04943dbb40128cf1ef
Publikováno v:
BMC Nursing, Vol 22, Iss 1, Pp 1-13 (2023)
Abstract Background A public health emergency can cause large numbers of deaths in a short period, with devastating social, economic and health consequences. Nurses are the main healthcare providers during such emergencies, and their competencies aff
Externí odkaz:
https://doaj.org/article/078cfc580f964560b110d3252a54e30e
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 17 (2024)
Externí odkaz:
https://doaj.org/article/361c394ba4ee40ecabbbabd728e71e63
Autor:
Xin Chen, Na Lin, Jin-Miao Li, Haixia Liu, Anmar Abu-Romman, Ebru Yaman, Fang Bian, Cintia S. de Paiva, Stephen C. Pflugfelder, De-Quan Li
Publikováno v:
Pharmaceutics, Vol 16, Iss 2, p 236 (2024)
Ectoine, a novel natural osmoprotectant, protects bacteria living in extreme environments. This study aimed to explore the therapeutic effect of ectoine for dry eye disease. An experimental dry eye model was created in C57BL/6 mice exposed to desicca
Externí odkaz:
https://doaj.org/article/ad818e3812ca4ed39de3fc488946258a
Publikováno v:
Asian Journal of Surgery, Vol 46, Iss 5, Pp 1975-1976 (2023)
Externí odkaz:
https://doaj.org/article/ce8741d253f54e5fad5bf48c942535ca
Autor:
Hui Fang, Fengmei Xu, Jin Du, Li Liang, Wei Li, Liya Shen, Xueying Wang, Chun Xu, Fang Bian, Yiming Mu
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 4, Pp 896-905 (2020)
Abstract Aims/Introduction This secondary analysis of the 24‐week SMART study examined the efficacy of add‐on saxagliptin or acarbose to metformin across different patient subgroups with type 2 diabetes mellitus, based on baseline characteristics
Externí odkaz:
https://doaj.org/article/160a2a3a97b546fcbfc665b2b650e770
Autor:
Ying Zhu, Jing Fang Bian, Da Qian Lu, Chi Ho To, Carly Siu-Yin Lam, King Kit Li, Feng Juan Yu, Bo Teng Gong, Qiong Wang, Xiao Wen Ji, Hong Mei Zhang, Hong Nian, Thomas Chuen Lam, Rui Hua Wei
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Purpose: Atropine, a non-selective muscarinic antagonist, effectively slows down myopia progression in human adolescents and several animal models. However, the underlying molecular mechanism is unclear. The current study investigated retinal protein
Externí odkaz:
https://doaj.org/article/a25857435517457f9ec67cc428b64a30
Publikováno v:
Energy for Sustainable Development. 73:1-12